Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12672056rdf:typepubmed:Citationlld:pubmed
pubmed-article:12672056lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C1155008lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C2266866lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12672056lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:12672056pubmed:issue4lld:pubmed
pubmed-article:12672056pubmed:dateCreated2003-4-2lld:pubmed
pubmed-article:12672056pubmed:abstractTextWe report here a role for cyclic AMP-responsive element-binding protein-1 (CREB-1) in B cell antigen receptor (BCR)-induced growth inhibition by IFN-gamma. BCR-induced proliferation is negatively regulated by IFN-gamma. Stimulation through BCR resulted in dose-dependent induction of CREB-1 binding to the consensus cyclic AMP-responsive element. Recombinant IFN-gamma inhibited the BCR-induced CREB-1 DNA binding activity and cell proliferation in B cells from signal transducer and activator of transcription-1 (STAT-1)(+/+), but not STAT-1(-/-) mice. These studies provide the first evidence for cross-talk between the STAT-1 and CREB-1 signaling pathways in IFN-gamma-mediated negative regulation of B cell activation.lld:pubmed
pubmed-article:12672056pubmed:languageenglld:pubmed
pubmed-article:12672056pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:citationSubsetIMlld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12672056pubmed:statusMEDLINElld:pubmed
pubmed-article:12672056pubmed:monthAprlld:pubmed
pubmed-article:12672056pubmed:issn0014-2980lld:pubmed
pubmed-article:12672056pubmed:authorpubmed-author:BondadaSubbar...lld:pubmed
pubmed-article:12672056pubmed:authorpubmed-author:MuthusamyNata...lld:pubmed
pubmed-article:12672056pubmed:authorpubmed-author:FrissoraFrank...lld:pubmed
pubmed-article:12672056pubmed:authorpubmed-author:ChenHui-ChenH...lld:pubmed
pubmed-article:12672056pubmed:authorpubmed-author:DurbinJoanJlld:pubmed
pubmed-article:12672056pubmed:issnTypePrintlld:pubmed
pubmed-article:12672056pubmed:volume33lld:pubmed
pubmed-article:12672056pubmed:ownerNLMlld:pubmed
pubmed-article:12672056pubmed:authorsCompleteYlld:pubmed
pubmed-article:12672056pubmed:pagination907-12lld:pubmed
pubmed-article:12672056pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:meshHeadingpubmed-meshheading:12672056...lld:pubmed
pubmed-article:12672056pubmed:year2003lld:pubmed
pubmed-article:12672056pubmed:articleTitleIFN-gamma-mediated inhibition of antigen receptor-induced B cell proliferation and CREB-1 binding activity requires STAT-1 transcription factor.lld:pubmed
pubmed-article:12672056pubmed:affiliationChildren's Research Institute, Wexner Institute for Pediatric Research, Columbus, OH 43205, USA.lld:pubmed
pubmed-article:12672056pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12672056lld:pubmed